These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 34895118)

  • 1. H19: A Vital Long Noncoding RNA in the Treatment of Diabetes and Diabetic Complications.
    Zhu L; Li Y; Xia F; Xue M; Wang Y; Jia D; Gao Y; Li L; Shi Y; Chen S; Xu G; Yuan C
    Curr Pharm Des; 2022; 28(12):1011-1018. PubMed ID: 34895118
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Extracellular vesicle-mimetic nanovesicles transport LncRNA-H19 as competing endogenous RNA for the treatment of diabetic wounds.
    Tao SC; Rui BY; Wang QY; Zhou D; Zhang Y; Guo SC
    Drug Deliv; 2018 Nov; 25(1):241-255. PubMed ID: 29334272
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recent Advances of LncRNA H19 in Diabetes LncRNA H19 in Diabetes.
    Bi Y; Wang Y; Sun X
    Horm Metab Res; 2022 Apr; 54(4):212-219. PubMed ID: 35413741
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long non-coding RNAs: The hidden players in diabetes mellitus-related complications.
    Hussein RM
    Diabetes Metab Syndr; 2023 Oct; 17(10):102872. PubMed ID: 37797393
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long Noncoding RNAs in Diabetes and Diabetic Complications.
    Leung A; Natarajan R
    Antioxid Redox Signal; 2018 Oct; 29(11):1064-1073. PubMed ID: 28934861
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Downregulation of long noncoding RNA H19 rescues hippocampal neurons from apoptosis and oxidative stress by inhibiting IGF2 methylation in mice with streptozotocin-induced diabetes mellitus.
    Yu JL; Li C; Che LH; Zhao YH; Guo YB
    J Cell Physiol; 2019 Jul; 234(7):10655-10670. PubMed ID: 30536889
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long noncoding RNA H19 acts as a miR-29b sponge to promote wound healing in diabetic foot ulcer.
    Li B; Zhou Y; Chen J; Wang T; Li Z; Fu Y; Zhai A; Bi C
    FASEB J; 2021 Jan; 35(1):e20526. PubMed ID: 33174326
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Knockdown of lncRNA H19 inhibits abnormal differentiation of small intestinal epithelial cells in diabetic mice.
    Shan TD; Lv SY; Tian ZB; Liu XS; Liu FG; Sun XG
    J Cell Physiol; 2018 Jan; 234(1):837-848. PubMed ID: 30078183
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LncRNA as a regulator in the development of diabetic complications.
    Geng M; Liu W; Li J; Yang G; Tian Y; Jiang X; Xin Y
    Front Endocrinol (Lausanne); 2024; 15():1324393. PubMed ID: 38390204
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LncRNA H19: a novel player in the regulation of diabetic kidney disease.
    Wu Q; Huang F
    Front Endocrinol (Lausanne); 2023; 14():1238981. PubMed ID: 37964955
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elevated hepatic expression of H19 long noncoding RNA contributes to diabetic hyperglycemia.
    Zhang N; Geng T; Wang Z; Zhang R; Cao T; Camporez JP; Cai SY; Liu Y; Dandolo L; Shulman GI; Carmichael GG; Taylor HS; Huang Y
    JCI Insight; 2018 May; 3(10):. PubMed ID: 29769440
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long noncoding RNA H19 promotes vascular remodeling by sponging let-7a to upregulate the expression of cyclin D1.
    Sun W; Lv J; Duan L; Lin R; Li Y; Li S; Fu C; Zhao L; Xin S
    Biochem Biophys Res Commun; 2019 Jan; 508(4):1038-1042. PubMed ID: 30551879
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current status and strategies of long noncoding RNA research for diabetic cardiomyopathy.
    Pant T; Dhanasekaran A; Fang J; Bai X; Bosnjak ZJ; Liang M; Ge ZD
    BMC Cardiovasc Disord; 2018 Oct; 18(1):197. PubMed ID: 30342478
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of Long Non-Coding RNA in Regulating ER Stress Response to the Progression of Diabetic Complications.
    Vijayalalitha R; Archita T; Juanitaa GR; Jayasuriya R; Amin KN; Ramkumar KM
    Curr Gene Ther; 2023; 23(2):96-110. PubMed ID: 35927920
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of the expression levels of lncRNAs H19 and MEG3 in patients with type 2 diabetes mellitus.
    Alrefai AA; Khader HF; Elbasuony HA; Elzorkany KM; Saleh AA
    Mol Biol Rep; 2023 Jul; 50(7):6075-6085. PubMed ID: 37294471
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circulating long noncoding RNAs H19 and GAS5 are associated with type 2 diabetes but not with diabetic retinopathy: A preliminary study.
    Fawzy MS; Abdelghany AA; Toraih EA; Mohamed AM
    Bosn J Basic Med Sci; 2020 Aug; 20(3):365-371. PubMed ID: 31999937
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LncRNA-H19 acts as a ceRNA to regulate HE4 expression by sponging miR-140 in human umbilical vein endothelial cells under hyperglycemia with or without α-Mangostin.
    Luo Y; Fang Z; Ling Y; Luo W
    Biomed Pharmacother; 2019 Oct; 118():109256. PubMed ID: 31362245
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Role of long non-coding RNA in diabetes mellitus and its complications].
    Li A; Zhang Z
    Sheng Wu Gong Cheng Xue Bao; 2016 Mar; 32(3):284-91. PubMed ID: 27349111
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A negative feedback loop of H19/miR-675/EGR1 is involved in diabetic nephropathy by downregulating the expression of the vitamin D receptor.
    Fan W; Peng Y; Liang Z; Yang Y; Zhang J
    J Cell Physiol; 2019 Aug; 234(10):17505-17513. PubMed ID: 30815865
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A competing endogenous RNA network identifies novel mRNA, miRNA and lncRNA markers for the prognosis of diabetic pancreatic cancer.
    Yao K; Wang Q; Jia J; Zhao H
    Tumour Biol; 2017 Jun; 39(6):1010428317707882. PubMed ID: 28639886
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.